The Wilms' tumor suppressor gene (wt1) product represses different functional classes of transcriptional activation domains.

AUTOR(ES)

Lee, T H

RESUMO

We have studied the ability of the wt1 tumor suppressor gene product to repress different classes of activation domains previously shown to stimulate the initiation and elongation steps of RNA polymerase II transcription in vivo. Repression assays revealed that WT1 represses all three classes of activation domains: Sp1 and CTF, which stimulate initiation (type I), human immunodeficiency virus type I Tat fused to a DNA-binding domain, which stimulates predominantly elongation (type IIA), and VP16, p53 and E2F1, which stimulate both initiation and elongation (type IIB). WT1 is capable of exerting its repression effect over a significant distance when positioned approximately 1700 bp from the core promoter. Deletion analysis of WT1 indicates that the responsible domain resides within the first 180 N-terminal amino acids of the protein. Nuclear run-ons analyzing the effects of WT1 on initiation of transcription demonstrate inhibition of this process. Our observations imply that WT1 can repress activators that stimulate initiation and/or elongation.

Documentos Relacionados

• The Wilms’ Tumor Suppressor Gene (wt1) Product Regulates Dax-1 Gene Expression during Gonadal Differentiation
• TaqI RFLPs at the Wilms' tumor gene (WT1)
• Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development.
• BASP1 Is a Transcriptional Cosuppressor for the Wilms' Tumor Suppressor Protein WT1
• Regulation of ornithine decarboxylase gene expression by the Wilms' tumor suppressor WT1.